ARYx Therapeutics files for $86.25 million IPO

WASHINGTON Thu Aug 30, 2007 5:44pm EDT

WASHINGTON Aug 30 (Reuters) - Biopharmaceutical company ARYx Therapeutics Inc filed with regulators on Thursday to raise up to $86.25 million in an initial public offering of common stock.

The company said in a registration statement with the U.S. Securities and Exchange Commission that Morgan Stanley, CIBC World Markets, Jefferies and Co, and Leerink Swann & Co are underwriting the IPO.

ARYx has applied to list its stock on Nasdaq under the symbol "ARYX" ARYX.O.

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.